Annual Revenue
$235.64 M
+$7.61 M+3.34%
December 31, 2023
Summary
- As of February 7, 2025, PBYI annual revenue is $235.64 million, with the most recent change of +$7.61 million (+3.34%) on December 31, 2023.
- During the last 3 years, PBYI annual revenue has risen by +$10.53 million (+4.68%).
- PBYI annual revenue is now -13.45% below its all-time high of $272.26 million, reached on December 31, 2019.
Performance
PBYI Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Revenue
$80.54 M
+$33.46 M+71.06%
September 30, 2024
Summary
- As of February 7, 2025, PBYI quarterly revenue is $80.54 million, with the most recent change of +$33.46 million (+71.06%) on September 30, 2024.
- Over the past year, PBYI quarterly revenue has increased by +$24.43 million (+43.53%).
- PBYI quarterly revenue is now -18.70% below its all-time high of $99.07 million, reached on March 31, 2019.
Performance
PBYI Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM Revenue
$243.57 M
+$24.43 M+11.15%
September 30, 2024
Summary
- As of February 7, 2025, PBYI TTM revenue is $243.57 million, with the most recent change of +$24.43 million (+11.15%) on September 30, 2024.
- Over the past year, PBYI TTM revenue has increased by +$14.44 million (+6.30%).
- PBYI TTM revenue is now -15.04% below its all-time high of $286.69 million, reached on June 30, 2019.
Performance
PBYI TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
PBYI Revenue Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +3.3% | +43.5% | +6.3% |
| 3 y3 years | +4.7% | +35.3% | +17.8% |
| 5 y5 years | -6.1% | +35.3% | +17.8% |
PBYI Revenue Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -6.9% | +3.3% | at high | +84.0% | -3.8% | +21.4% |
| 5 y | 5-year | -13.4% | +4.7% | -18.0% | +84.0% | -10.5% | +21.4% |
| alltime | all time | -13.4% | +751.1% | -18.7% | +1225.4% | -15.0% | +3908.1% |
Puma Biotechnology Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $80.54 M(+71.1%) | $243.57 M(+11.1%) |
| Jun 2024 | - | $47.08 M(+7.6%) | $219.14 M(-3.3%) |
| Mar 2024 | - | $43.77 M(-39.4%) | $226.63 M(-3.8%) |
| Dec 2023 | $235.64 M(+3.3%) | $72.18 M(+28.6%) | $235.64 M(+2.8%) |
| Sep 2023 | - | $56.12 M(+2.8%) | $229.13 M(-0.4%) |
| Jun 2023 | - | $54.57 M(+3.4%) | $230.12 M(-2.1%) |
| Mar 2023 | - | $52.77 M(-19.6%) | $235.07 M(+3.1%) |
| Dec 2022 | $228.03 M(-9.9%) | $65.67 M(+15.0%) | $228.03 M(+4.7%) |
| Sep 2022 | - | $57.10 M(-4.1%) | $217.71 M(+5.2%) |
| Jun 2022 | - | $59.52 M(+30.1%) | $206.86 M(+3.1%) |
| Mar 2022 | - | $45.74 M(-17.4%) | $200.72 M(-20.7%) |
| Dec 2021 | $253.16 M | $55.36 M(+19.7%) | $253.16 M(+1.1%) |
| Sep 2021 | - | $46.24 M(-13.4%) | $250.35 M(-1.8%) |
| Jun 2021 | - | $53.38 M(-45.6%) | $254.86 M(-6.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2021 | - | $98.17 M(+86.8%) | $272.06 M(+20.9%) |
| Dec 2020 | $225.11 M(-17.3%) | $52.56 M(+3.6%) | $225.11 M(-4.4%) |
| Sep 2020 | - | $50.75 M(-28.1%) | $235.47 M(-2.3%) |
| Jun 2020 | - | $70.58 M(+37.8%) | $241.07 M(+7.4%) |
| Mar 2020 | - | $51.22 M(-18.6%) | $224.41 M(-17.6%) |
| Dec 2019 | $272.26 M(+8.5%) | $62.92 M(+11.7%) | $272.26 M(-2.9%) |
| Sep 2019 | - | $56.35 M(+4.5%) | $280.42 M(-2.2%) |
| Jun 2019 | - | $53.92 M(-45.6%) | $286.69 M(+1.1%) |
| Mar 2019 | - | $99.07 M(+39.4%) | $283.54 M(+13.0%) |
| Dec 2018 | $250.99 M(+806.6%) | $71.08 M(+13.5%) | $250.99 M(+24.5%) |
| Sep 2018 | - | $62.63 M(+23.4%) | $201.52 M(+39.0%) |
| Jun 2018 | - | $50.77 M(-23.7%) | $144.97 M(+53.9%) |
| Mar 2018 | - | $66.52 M(+207.8%) | $94.20 M(+240.3%) |
| Dec 2017 | $27.68 M | $21.61 M(+255.6%) | $27.68 M(+355.6%) |
| Sep 2017 | - | $6.08 M | $6.08 M |
FAQ
- What is Puma Biotechnology annual revenue?
- What is the all time high annual revenue for Puma Biotechnology?
- What is Puma Biotechnology annual revenue year-on-year change?
- What is Puma Biotechnology quarterly revenue?
- What is the all time high quarterly revenue for Puma Biotechnology?
- What is Puma Biotechnology quarterly revenue year-on-year change?
- What is Puma Biotechnology TTM revenue?
- What is the all time high TTM revenue for Puma Biotechnology?
- What is Puma Biotechnology TTM revenue year-on-year change?
What is Puma Biotechnology annual revenue?
The current annual revenue of PBYI is $235.64 M
What is the all time high annual revenue for Puma Biotechnology?
Puma Biotechnology all-time high annual revenue is $272.26 M
What is Puma Biotechnology annual revenue year-on-year change?
Over the past year, PBYI annual revenue has changed by +$7.61 M (+3.34%)
What is Puma Biotechnology quarterly revenue?
The current quarterly revenue of PBYI is $80.54 M
What is the all time high quarterly revenue for Puma Biotechnology?
Puma Biotechnology all-time high quarterly revenue is $99.07 M
What is Puma Biotechnology quarterly revenue year-on-year change?
Over the past year, PBYI quarterly revenue has changed by +$24.43 M (+43.53%)
What is Puma Biotechnology TTM revenue?
The current TTM revenue of PBYI is $243.57 M
What is the all time high TTM revenue for Puma Biotechnology?
Puma Biotechnology all-time high TTM revenue is $286.69 M
What is Puma Biotechnology TTM revenue year-on-year change?
Over the past year, PBYI TTM revenue has changed by +$14.44 M (+6.30%)